We have emphasized this before, but we want to talk about it again because it recently came up in a general primary care journal: “active surveillance” and “watchful waiting” are often used interchangeably — by patients and their partners and by some doctors too … but they aren’t the same thing at all. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, goals, patient, selection, surveillance, waiting, watchful | 5 Comments »
Since Prostate Cancer International runs an online support group (OSG) for patients, we were obviously very interested to see a newly published article by a German research group on the effects of OSGs on patients’ decision-making processes. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: decision-making, group, online, selection, support, Treatment | Leave a comment »
The question of how best to set the spectrum of criteria that indicate the suitability of an individual patient as a good candidate for active surveillance as opposed to early treatment is (as yet) not well answered. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, criteria, patient, selection, surveillance | Leave a comment »
A paper to be presented at the Genitourinary Cancers Synposium today, suggests that use of a liquid biopsy and analysis of single circulating tumor cells (CTCs) may be helpful in determining therapy for men with metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biopsy, cell, circulating, CTC, liquid, selection, Treatment, tumor | Leave a comment »
In this month’s issue of the Journal of Urology, Dr. Peter Carroll (of UCSF) and Dr. Mark Dall’Era (formerly of UCSF and now at UCDavis) have contributed an editorial entitled “What is the optimal way to select candidates for active surveillance of prostate cancer?” … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, expectant, guidelines, Management, patient, selection, surveillance | 1 Comment »
This morning we have a series of four more prostate cancer-related summary reports from the 14th annual meeting of the Society for Urologic Oncology (SUO) available on the UroToday web site (which is freely accessible to patients, but you do have to register to access it). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: ctive surveilance, identification, patient, selection | 2 Comments »
It is well understood that current Western screening and diagnostic processes commonly identify patients with low volume, low Gleason grade prostate cancer tumors (e.g., a single biopsy core with < 10 percent of the core positive for cancer of Gleason score 3 + 3 = 6). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: candidate, focal therapy, incidence, risk, selection | 12 Comments »
It is well understood that there can be big differences between what we are told and what we later say and think that we heard. It is also the case that what we are told may commonly reflect the beliefs of the person doing the telling (as opposed to actual, factual information). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: decision, expectation, perspective, selection, Treatment | 7 Comments »
A small study from the University of Miami has confirmed the unsurprising but important information that patients are heavily influenced by physicians in their decision to elect (or not elect) active surveillance (AS) as a management option for low-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance, influence, physician, selection, Treatment | Leave a comment »
A recent French study nicely illustrates the very real problem associated with the selection of the best candidates for active surveillance and the exclusion from active surveillance of patients who probably would be better served by immediate treatment. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: active surveillance, criteria, prognosis, selection | 6 Comments »
There are only three notable reports in today’s news stream … but one of them may be very important (if you can understand it) … … READ MORE …
Filed under: Diagnosis, Management, Prevention, Risk, Treatment | Tagged: risk, selection, selenium, Treatment | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 